Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adma Biologics
(NQ:
ADMA
)
13.29
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,199
Open
13.29
Bid (Size)
13.04 (3)
Ask (Size)
13.52 (1)
Prev. Close
13.29
Today's Range
13.29 - 13.29
52wk Range
3.060 - 13.84
Shares Outstanding
196,357,149
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biotech Arvinas Stock Earns 82 RS Rating
July 17, 2024
The Relative Strength (RS) Rating for Arvinas stock entered a new percentile Wednesday, with a rise from 62 to 82.
Via
Investor's Business Daily
Denali Therapeutics Stock Gets Technical Rating Upgrade
July 16, 2024
Denali Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
Via
Investor's Business Daily
Performance
YTD
+192.09%
+192.09%
1 Month
+27.30%
+27.30%
3 Month
+120.03%
+120.03%
6 Month
+169.57%
+169.57%
1 Year
+272.27%
+272.27%
More News
Read More
3 Millionaire-Making Stock Picks With Astounding Growth Potential
July 13, 2024
Via
InvestorPlace
How Is The Market Feeling About ADMA Biologics?
July 11, 2024
Via
Benzinga
Bull Run Alert: 3 Stocks Set to Soar in the Coming Months
July 11, 2024
Via
InvestorPlace
Expert Ratings For ADMA Biologics
July 09, 2024
Via
Benzinga
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
June 20, 2024
Via
Benzinga
ADMA Biologics Analysts Increase Their Forecasts After Upbeat Results
May 10, 2024
Via
Benzinga
A Closer Look at 6 Analyst Recommendations For ADMA Biologics
March 26, 2024
Via
Benzinga
UroGen Pharma Stock Earns 91 RS Rating
June 27, 2024
Via
Investor's Business Daily
Arcellx Stock Earns Relative Strength Rating Upgrade
June 21, 2024
Via
Investor's Business Daily
Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
June 20, 2024
Via
Investor's Business Daily
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
June 14, 2024
Via
Investor's Business Daily
Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
June 12, 2024
Via
Investor's Business Daily
Krystal Biotech Stock Sees RS Rating Jump To 91
June 11, 2024
Via
Investor's Business Daily
Forecasting The Future: 4 Analyst Projections For ADMA Biologics
February 29, 2024
Via
Benzinga
Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
May 10, 2024
Via
Benzinga
Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday
May 10, 2024
Via
Benzinga
ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
May 09, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Chart Of The Day: ADMA Biologics - Hitting New Highs
May 06, 2024
Via
Talk Markets
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
May 02, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
March 11, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
March 05, 2024
From
ADMA Biologics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.